Sign in

Publications

Search in 13060 publications:

RSS
Time frame
13060 Publication(s)
Feb 25, 2023
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Messerich N, Uda N, Volken T, Cogliatti S, Lehmann T, Holbro A, Benz R, Graf L, Gupta V, Jochum W, Demmer I, Rao T, Silzle T. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers (Basel) 2023; 15
Feb 25, 2023
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Feb 25, 2023

Cancers (Basel) 2023; 15

Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobias

more
Feb 23, 2023
Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review.
Burkhardt O, Abt D, Engeler D, Schmid H, Müllhaupt G, Zumstein V. Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review. Eur Urol Focus 2023
Feb 23, 2023
Prostatic Artery Embolization in Patients with Prostate Cancer: A Systematic Review.
Feb 23, 2023

Eur Urol Focus 2023

Burkhardt Orlando, Abt Dominik, Engeler Daniel, Schmid Hans-Peter, Müllhaupt Gautier, Zumstein Valentin

more
Feb 20, 2023
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Fischer S, Rothermundt C, Stalder O, Terbuch A, Hermanns T, Zihler D, Müller-Stich B, Fankhauser C, Hirschi-Blickenstorfer A, Seifert B, Alex Kluth L, Ufe M, Mingrone W, Templeton A, Fischer N, Rothschild S, Woelky R, Gillessen S, Cathomas R. The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study. Eur Urol Open Sci 2023; 50:57-60.
Feb 20, 2023
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Feb 20, 2023

Eur Urol Open Sci 2023; 50:57-60

Fischer Stefanie, Rothermundt Christian, Stalder Odile, Terbuch Angelika, Hermanns Thomas, Zihler Deborah, Müller-Stich Beat P, Fankhauser Christian Daniel, Hirschi-Blickenstorfer Anita, Seifert Bettina, Alex Kluth Luis, Ufe Mark-Peter, Mingrone Walter, Templeton Arnoud J, Fischer Natalie Fischer, Rothschild Sacha I, Woelky Regina, Gillessen Silke, Cathomas Richard

more
Feb 17, 2023
[SOP eyelid tumors].
Varde M, Heindl L, Kakkassery V. [SOP eyelid tumors]. Ophthalmologie 2023; 120:271-272.
Feb 17, 2023
[SOP eyelid tumors].
Feb 17, 2023

Ophthalmologie 2023; 120:271-272

Varde Meghana, Heindl L M, Kakkassery V

more
Feb 16, 2023
Factors associated with self-reported pain and hand function following dorsal wrist ganglion excision.
Greminger M, Koopman J, van Kooij Y, Hoogendam L, Smit J, Slijper H, Selles R, Calcagni M, SUpExOr Study Group, Hand-Wrist Study Group. Factors associated with self-reported pain and hand function following dorsal wrist ganglion excision. J Hand Surg Eur Vol 2023; 48:551-560.
Feb 16, 2023
Factors associated with self-reported pain and hand function following dorsal wrist ganglion excision.
Feb 16, 2023

J Hand Surg Eur Vol 2023; 48:551-560

Greminger Martina, Koopman Jaimy Emerentiana, van Kooij Yara Eline, Hoogendam Lisa, Smit Jeroen, Slijper Harm Pieter, Selles Ruud Willem, Calcagni Maurizio, SUpExOr Study Group, Hand-Wrist Study Group

more
Feb 16, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Jörger M, Hundsberger T, Haefliger S, von Moos R, Hottinger A, Kaindl T, Engelhardt M, Marszewska M, Lane H, Roth P, Stathis A. Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Invest New Drugs 2023; 41:267-275.
Feb 16, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Feb 16, 2023

Invest New Drugs 2023; 41:267-275

Jörger Markus, Hundsberger Thomas, Haefliger Simon, von Moos Roger, Hottinger Andreas F, Kaindl Thomas, Engelhardt Marc, Marszewska Michalina, Lane Heidi, Roth Patrick, Stathis Anastasios

more
Feb 16, 2023
Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.
Pratsinis M, Müllhaupt G, Güsewell S, Betschart P, Zumstein V, Engeler D, Schmid H, Lamb A, Abt D. Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia. World J Urol 2023
Feb 16, 2023
Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.
Feb 16, 2023

World J Urol 2023

Pratsinis Manolis, Müllhaupt Gautier, Güsewell Sabine, Betschart Patrick, Zumstein Valentin, Engeler Daniel, Schmid Hans-Peter, Lamb Alastair D, Abt Dominik

more
Feb 16, 2023
Are Predictors for Overall Mortality in COPD Patients Robust over Time?
Sievi N, Sepin J, Roeder M, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Clarenbach C, Kohler M. Are Predictors for Overall Mortality in COPD Patients Robust over Time?. J Clin Med 2023; 12
Feb 16, 2023
Are Predictors for Overall Mortality in COPD Patients Robust over Time?
Feb 16, 2023

J Clin Med 2023; 12

Sievi Noriane Andrina, Sepin Jerome, Roeder Maurice, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Joerg Daniel, Thurnheer Robert, Clarenbach Christian F, Kohler Malcolm

more
Feb 15, 2023
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O, Deng Y, Frischknecht L, Wehmeier C, Villard J, Ferrari-Lacraz S, Golshayan D, Gannagé M, Binet I, Wirthmueller U, Sidler D, Schachtner T, Schaub S, Nilsson J, Swiss Transplant Cohort Study. Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study. Front Immunol 2023; 14:1104371.
Feb 15, 2023
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
Feb 15, 2023

Front Immunol 2023; 14:1104371

de Rougemont Olivier, Deng Yun, Frischknecht Lukas, Wehmeier Caroline, Villard Jean, Ferrari-Lacraz Sylvie, Golshayan Déla, Gannagé Monique, Binet Isabelle, Wirthmueller Urs, Sidler Daniel, Schachtner Thomas, Schaub Stefan, Nilsson Jakob, Swiss Transplant Cohort Study

more
Feb 14, 2023
Pharmacists' attitudes toward influenza vaccination: does the COVID-19 pandemic make a difference?
Langer R, Thanner M. Pharmacists' attitudes toward influenza vaccination: does the COVID-19 pandemic make a difference?. Explor Res Clin Soc Pharm 2023; 9:100235.
Feb 14, 2023
Pharmacists' attitudes toward influenza vaccination: does the COVID-19 pandemic make a difference?
Feb 14, 2023

Explor Res Clin Soc Pharm 2023; 9:100235

Langer Roland, Thanner Mirjam

more
Feb 14, 2023
Proposed new classification for internal carotid artery segmental agenesis based on embryologic and angiographic correlation.
Bonasia S, Smajda S, Ciccio G, Bojanowski M, Robert T. Proposed new classification for internal carotid artery segmental agenesis based on embryologic and angiographic correlation. Surg Radiol Anat 2023
Feb 14, 2023
Proposed new classification for internal carotid artery segmental agenesis based on embryologic and angiographic correlation.
Feb 14, 2023

Surg Radiol Anat 2023

Bonasia Sara, Smajda Stanislas, Ciccio Gabriele, Bojanowski Michel W, Robert Thomas

more
Feb 14, 2023
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy.
Zděblová Čermáková Z, Hurník P, Konvalinka D, Štembírek J, Paračková T, Resová K, Cvek J, Blažek T, Knybel L, Formánek M, Gachechiladze M, Jörger M, Soltermann A, Škarda J, Motyka O, Janoutová J. HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina (Kaunas) 2023; 59
Feb 14, 2023
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy.
Feb 14, 2023

Medicina (Kaunas) 2023; 59

Zděblová Čermáková Zuzana, Hurník Pavel, Konvalinka David, Štembírek Jan, Paračková Tereza, Resová Kamila, Cvek Jakub, Blažek Tomáš, Knybel Lukáš, Formánek Martin, Gachechiladze Mariam, Jörger Markus, Soltermann Alex, Škarda Jozef, Motyka Oldřich, Janoutová Jana

more
Feb 13, 2023
The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
Bonny O, Fuster D, Seeger H, Ernandez T, Buchkremer F, Wuerzner G, Dhayat N, Ritter A, Stoermann-Chopard C, Segerer S, Haeusermann T, Pasch A, Kim M, Mayr M, Krapf R, Roth B, Bochud M, Mohebbi N, Wagner C. The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland. Kidney Blood Press Res 2023
Feb 13, 2023
The Swiss Kidney Stone Cohort (SKSC), a longitudinal, multi-centric, observational cohort to study course and causes of kidney stone disease in Switzerland.
Feb 13, 2023

Kidney Blood Press Res 2023

Bonny Olivier, Fuster Daniel G, Seeger Harald, Ernandez Thomas, Buchkremer Florian, Wuerzner Gregoire, Dhayat Nasser A, Ritter Alexander, Stoermann-Chopard Catherine, Segerer Stephan, Haeusermann Tanja, Pasch Andreas, Kim Minjeong, Mayr Michael, Krapf Reto, Roth Beat, Bochud Murielle, Mohebbi Nilufar, Wagner Carsten A

more
Feb 11, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.
Feb 11, 2023
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Feb 11, 2023

Obes Surg 2023:1-9

Jensen Anders Boisen, Renström Frida, Aczel Stefan, Folie Patrick, Biraima Magdalena, Beuschlein Felix, Bilz Stefan

more
Feb 10, 2023
[Diagnosis and treatment of benign eyelid tumors].
Varde M, Heindl L, Kakkassery V. [Diagnosis and treatment of benign eyelid tumors]. Ophthalmologie 2023; 120:240-251.
Feb 10, 2023
[Diagnosis and treatment of benign eyelid tumors].
Feb 10, 2023

Ophthalmologie 2023; 120:240-251

Varde Meghana, Heindl L M, Kakkassery V

more
Feb 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Loo L, Waller M, Moreno C, Cole A, Stella A, Pop O, Jochum A, Ali O, Denes C, Hamoudi Z, Chung F, Aggarwal A, Low J, Patel K, Siddiquee R, Kang T, Mathivanan S, Mackay J, Jochum W, Flatz L, Hesselson D, Turville S, Neely G. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs. PLoS Biol 2023; 21:e3001967.
Feb 9, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Feb 9, 2023

PLoS Biol 2023; 21:e3001967

Loo Lipin, Waller Matthew A, Moreno Cesar L, Cole Alexander J, Stella Alberto Ospina, Pop Oltin-Tiberiu, Jochum Ann-Kristin, Ali Omar Hasan, Denes Christopher E, Hamoudi Zina, Chung Felicity, Aggarwal Anupriya, Low Jason K K, Patel Karishma, Siddiquee Rezwan, Kang Taeyoung, Mathivanan Suresh, Mackay Joel P, Jochum Wolfram, Flatz Lukas, Hesselson Daniel, Turville Stuart G, Neely G Gregory

more
Feb 9, 2023
[Diagnosis and treatment of malignant eyelid tumors].
Gniesmer S, Sonntag S, Schiemenz C, Ranjbar M, Heindl L, Varde M, Emmert S, Grisanti S, Kakkassery V. [Diagnosis and treatment of malignant eyelid tumors]. Ophthalmologie 2023; 120:262-270.
Feb 9, 2023
[Diagnosis and treatment of malignant eyelid tumors].
Feb 9, 2023

Ophthalmologie 2023; 120:262-270

Gniesmer S, Sonntag S R, Schiemenz C, Ranjbar M, Heindl L M, Varde Meghana, Emmert S, Grisanti S, Kakkassery V

more
Feb 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland.
Çakar E, Oniangue-Ndza C, Schneider R, Klijn S, Vogl U, Rothermundt C, May J. Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland. Pharmacoecon Open 2023
Feb 9, 2023
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland.
Feb 9, 2023

Pharmacoecon Open 2023

Çakar Esra, Oniangue-Ndza César, Schneider Ralph P, Klijn Sven L, Vogl Ursula M, Rothermundt Christian, May Jessica R

more
Feb 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Gillessen S, Procopio G, Hayoz S, Kremer E, Schwitter M, Caffo O, Lorente D, Pedrazzini A, Roubaud G, Nenan S, Omlin A, Buttigliero C, Delgado Mingorance J, González-Del-Alba A, Delgado M, Nolè F, Turco F, Mestre R, Ribi K, Cathomas R. Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). J Clin Oncol 2023; 41:3608-3615.
Feb 8, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Feb 8, 2023

J Clin Oncol 2023; 41:3608-3615

Gillessen Silke, Procopio Giuseppe, Hayoz Stefanie, Kremer Eloïse, Schwitter Michael, Caffo Orazio, Lorente David, Pedrazzini Augusto, Roubaud Guilhem, Nenan Soazig, Omlin Aurelius, Buttigliero Consuelo, Delgado Mingorance Juan Ignacio, González-Del-Alba Aránzazu, Delgado Maria Teresa, Nolè Franco, Turco Fabio, Mestre Ricardo Pereira, Ribi Karin, Cathomas Richard

more
Feb 7, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.
Brandstadter J, De Martin A, Lütge M, Ferreira A, Gaudette B, Stanossek Y, Wang S, Gonzalez M, Camiolo E, Wertheim G, Austin B, Allman D, Salim M, Fajgenbaum D, Aster J, Ludewig B, Maillard I. A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease. bioRxiv 2023
Feb 7, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.
Feb 7, 2023

bioRxiv 2023

Brandstadter Joshua D, De Martin Angelina, Lütge Mechthild, Ferreira Antonio, Gaudette Brian T, Stanossek Yves, Wang Shumei, Gonzalez Michael V, Camiolo Edward, Wertheim Gerald, Austin Bridget, Allman David, Salim M, Fajgenbaum David C, Aster Jon C, Ludewig Burkhard, Maillard Ivan

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy